Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence.

BACKGROUND AND AIM Chronic Obstructive Pulmonary Disease (COPD), although largely preventable, is a great health burden in all the countries worldwide. Statistics of morbidity and mortality of COPD show the need for correct management of the disease. Chronic Obstructive Respiratory Diseases (DRG 88) are in 9th place for discharge in in-patient hospital admission. It is necessary to establish specific indicators which are efficacious and relevant for the patient, the doctor and the health manager. This study will analyse the information in respect of hospital admissions (Hospital discharge database) in Puglia for the period 2000-2005. METHODS The analysis was carried out utilising the Puglia Region hospital patient discharge database, selecting those patients with admission for chronic respiratory disease as principal or secondary diagnosis. RESULTS Chronic respiratory diseases are more frequent in males and in people over 45 years old with frequency increasing with age. Geographical distribution shows that there are greater rates of hospitalisation in big cities and in the neighbourhood of industrial areas. Although the trend over time is slight. A higher percentage of re-admission has been found for patients with COPD, and the interval between the two admissions occurs within one or two months; the diagnosis at the second admission is the same as for the first. 10.6% of discharge forms report one diagnosis, especially in patients older than 65 years of age. Little could be said about diagnostic procedures because these are not reported on the discharge form. CONCLUSION Hospitalisation data confirms expectations regarding age and sex of patients. The high hospitalisation rates indicate that in-patients care still remains the only viable treatment for COPD and other chronic respiratory diseases. The high number of exacerbations reflect the absence of out-patients service or community care, and the same diagnosis in more than one episode shows the lack of efficiency of health services and disease management. This data is necessary to understand disease distribution and the modification of disease management in order to reduce health care costs, to increase efficacy in disease control and to limit repeated exacerbation and so to obtain the maximum benefit for the patients.

[1]  Jiaquan Xu,et al.  Deaths: final data for 2007. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[2]  G. Donaldson,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease (vol 57, pg 847, 2002) , 2008 .

[3]  M. Miravitlles,et al.  Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare , 2008, International journal of clinical practice.

[4]  Edwin K Silverman,et al.  Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression? , 2007, Proceedings of the American Thoracic Society.

[5]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[6]  C. Roberts,et al.  Variability in the organisation and management of hospital care for COPD exacerbations in the UK. , 2007, Respiratory medicine.

[7]  T. Wong,et al.  Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong , 2007, Thorax.

[8]  T. Keistinen,et al.  The COPD-induced hospitalization burden from first admission to death. , 2007, Respiratory medicine.

[9]  J. Roca,et al.  The impact of home hospitalization on healthcare costs of exacerbations in COPD patients , 2007, The European Journal of Health Economics.

[10]  E. McGlynn,et al.  The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. , 2006, Chest.

[11]  R. Grol,et al.  The feasibility of a primary care model for the management of COPD. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.

[12]  P. Halfon,et al.  Validation of the Potentially Avoidable Hospital Readmission Rate as a Routine Indicator of the Quality of Hospital Care , 2006, Medical care.

[13]  Giovanni Viegi,et al.  Epidemiology of chronic obstructive pulmonary disease: Health effects of air pollution , 2006, Respirology.

[14]  M. Decramer,et al.  Integrated care prevents hospitalisations for exacerbations in COPD patients , 2006, European Respiratory Journal.

[15]  P. Burge Prevention of exacerbations: how are we doing and can we do better? , 2006, Proceedings of the American Thoracic Society.

[16]  Antonella Zanobetti,et al.  The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. , 2006, American journal of epidemiology.

[17]  T. Seemungal,et al.  Effects of exacerbations and seasonality on exhaled nitric oxide in COPD , 2005, European Respiratory Journal.

[18]  R. Burnett,et al.  Effect of short-term exposure to low levels of gaseous pollutants on chronic obstructive pulmonary disease hospitalizations. , 2005, Environmental research.

[19]  J. Soler-Cataluña,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005 .

[20]  L. Shepstone,et al.  Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial , 2005, BMJ : British Medical Journal.

[21]  P. Ho,et al.  Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong , 2004, Journal of medical virology.

[22]  J. Garcia-Aymerich,et al.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study , 2003, Thorax.

[23]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[24]  Ramon Gisbert,et al.  Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. , 2002, Chest.

[25]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[26]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[27]  M. Malesker,et al.  Pharmacoeconomic evaluation of COPD. , 2000, Chest.

[28]  G. Trakada,et al.  Chronic obstructive pulmonary disease management among primary healthcare physicians. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[29]  J. Schwartz,et al.  Air pollution and cause-specific mortality in Milan, Italy, 1980-1989. , 1999, Archives of environmental health.

[30]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[31]  Jiachun Lu,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China , 2007 .

[32]  Albert Alonso,et al.  A new model for home care for COPD. , 2004, Studies in health technology and informatics.

[33]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[34]  S. Moolgavkar Air pollution and hospital admissions for chronic obstructive pulmonary disease in three metropolitan areas in the United States. , 2000, Inhalation toxicology.

[35]  G. Marks,et al.  Primary care Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease , 2022 .